CD4 and neoplasm: In the current study, RT was observed to significantly up-regulate the proportion of Tregs in CD4+ T cells in tumor tissues (Figure 6E), and significantly down-regulate the number of CD45+ leukocytes in tumor tissues (Figure S6A) and the spleen (Figure S8A).